ClinConnect ClinConnect Logo
Search / Trial NCT06918054

Hepatoprotective for Children and Adolescent With Acute Lymphoblastic Leukemia

Launched by AIN SHAMS UNIVERSITY · Apr 6, 2025

Trial Information

Current as of October 04, 2025

Recruiting

Keywords

Acute Lymphoblastic Leukemia Hepatoprotective Program

ClinConnect Summary

This clinical trial is focused on protecting the liver in children and adolescents who have recently been diagnosed with acute lymphoblastic leukemia (ALL) and are starting their chemotherapy treatment. The research aims to monitor and prevent any liver damage that may occur during the early stages of chemotherapy. The study is currently looking for participants, specifically children and teenagers aged 2 to 18 years who are just beginning their treatment for ALL at Ain Shams Hospital.

To participate in this trial, children must be newly diagnosed with ALL and not have any known chronic liver diseases. If eligible, participants can expect to receive careful monitoring during their chemotherapy to help ensure their liver stays healthy throughout the treatment process. This study is important because it could lead to better care for young patients undergoing chemotherapy, helping to minimize potential side effects related to liver health.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Children and adolescents aged from 2 to 18 years newly diagnosed with acute lymphoblastic leukemia during induction phase of chemotherapy treated at Ain Shams
  • Exclusion Criteria:
  • Known chronic liver disease.

About Ain Shams University

Ain Shams University, established in Cairo, Egypt, is a prestigious higher education institution renowned for its commitment to academic excellence and research innovation. As a clinical trial sponsor, the university leverages its extensive resources and expertise in various medical and scientific disciplines to advance healthcare through rigorous research initiatives. With a focus on ethical practices and adherence to regulatory standards, Ain Shams University aims to contribute to the development of new therapies and improve patient outcomes, fostering collaboration among researchers, healthcare professionals, and industry partners in the pursuit of medical advancements.

Locations

Cairo, Egypt

Cairo, Abbasia, Egypt

Patients applied

0 patients applied

Trial Officials

Manal El-Sayed, MD

Study Chair

Faculty of Medicine Ain Shams University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported